Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis.

OBJECTIVE To investigate the biologic significance of Smad3 in the progression of osteoarthritis (OA), the crosstalk between Smad3 and activating transcription factor 2 (ATF-2) in the transforming growth factor beta (TGFbeta) signaling pathway, and the effects of ATF-2 overexpression and p38 activation in chondrocyte differentiation. METHODS Joint disease in Smad3-knockout (Smad3(-/-)) mice was examined by microfocal computed tomography and histologic analysis. Numerous in vitro methods including immunostaining, real-time polymerase chain reaction, Western blotting, an ATF-2 DNA-binding assay, and a p38 kinase activity assay were used to study the various signaling responses and protein interactions underlying the altered chondrocyte phenotype in Smad3(-/-) mice. RESULTS In Smad3(-/-) mice, an end-stage OA phenotype gradually developed. TGFbeta-activated kinase 1 (TAK1)/ATF-2 signaling was disrupted in Smad3(-/-) mouse chondrocytes at the level of p38 MAP kinase (MAPK) activation, resulting in reduced ATF-2 phosphorylation and transcriptional activity. Reintroduction of Smad3 into Smad3(-/-) cells restored the normal p38 response to TGFbeta. Phosphorylated p38 formed a complex with Smad3 by binding to a portion of Smad3 containing both the MAD homology 1 and linker domains. Additionally, Smad3 inhibited the dephosphorylation of p38 by MAPK phosphatase 1 (MKP-1). Both ATF-2 overexpression and p38 activation repressed type X collagen expression in wild-type and Smad3(-/-) chondrocytes. P38 was detected in articular cartilage and perichondrium; articular and sternal chondrocytes expressed p38 isoforms alpha, beta, and gamma, but not delta. CONCLUSION Smad3 is involved in both the onset and progression of OA. Loss of Smad3 abrogates TAK1/ATF-2 signaling, most likely by disrupting the Smad3-phosphorylated p38 complex, thereby promoting p38 dephosphorylation and inactivation by MKP-1. ATF-2 and p38 activation inhibit chondrocyte hypertrophy. Modulation of p38 isoform activity may provide a new therapeutic approach for OA.

[1]  E. Schwarz,et al.  TAK1 Regulates Cartilage and Joint Development via the MAPK and BMP Signaling Pathways , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Z. Werb,et al.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. , 2009, Arthritis and rheumatism.

[3]  Paul Tempst,et al.  Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. , 2009, Molecular cell.

[4]  Sho Fujisawa,et al.  Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways , 2009, Cell.

[5]  Min Xie,et al.  TAK1 is an essential regulator of BMP signalling in cartilage , 2009, The EMBO journal.

[6]  I. Matsuura,et al.  Transforming Growth Factor-β-inducible Phosphorylation of Smad3* , 2009, Journal of Biological Chemistry.

[7]  D. Moore,et al.  Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage. , 2008, Arthritis and rheumatism.

[8]  P. LuValle,et al.  Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression , 2008, Mechanisms of Development.

[9]  R. O’Keefe,et al.  Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. , 2008, Arthritis and rheumatism.

[10]  T. Hardingham.  Extracellular matrix and pathogenic mechanisms in osteoarthritis , 2008, Current rheumatology reports.

[11]  H. Asahara,et al.  Molecular network of cartilage homeostasis and osteoarthritis , 2008, Medicinal research reviews.

[12]  G. Firestein,et al.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[13]  A. Flenniken,et al.  Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. , 2007, Genes & development.

[14]  P. D. Kraan,et al.  TGF-β and osteoarthritis , 2007 .

[15]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[16]  R. Dickinson,et al.  Diverse physiological functions for dual-specificity MAP kinase phosphatases , 2006, Journal of Cell Science.

[17]  R. Axmann,et al.  Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis , 2006 .

[18]  S. Murakami,et al.  Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. McMahon,et al.  BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[21]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[22]  E. Schwarz,et al.  Smad3‐Deficient Chondrocytes Have Enhanced BMP Signaling and Accelerated Differentiation , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[24]  R. O’Keefe,et al.  Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis. , 2005, Molecular aspects of medicine.

[25]  Fang Liu,et al.  Cyclin-dependent kinases regulate the antiproliferative function of Smads , 2004, Nature.

[26]  T. Underhill,et al.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. , 2004, The Biochemical journal.

[27]  T. Underhill,et al.  MAP kinases in chondrocyte differentiation. , 2003, Developmental biology.

[28]  E. Schwarz,et al.  ATF-2 cooperates with Smad3 to mediate TGF-β effects on chondrocyte maturation , 2003 .

[29]  Jiahuai Han,et al.  Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. , 2002, The Journal of biological chemistry.

[30]  J. Gurdon,et al.  Nuclear exclusion of Smad2 is a mechanism leading to loss of competence , 2002, Nature Cell Biology.

[31]  D. Heymann,et al.  Recent advances in TGF-β effects on chondrocyte metabolism , 2002 .

[32]  C. Deng,et al.  TGF-β/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage , 2001, The Journal of cell biology.

[33]  Xia Lin,et al.  Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210 , 2000, The Journal of Biological Chemistry.

[34]  F. Beier,et al.  Activating Transcription Factor 2 Is Necessary for Maximal Activity and Serum Induction of the Cyclin A Promoter in Chondrocytes* , 2000, The Journal of Biological Chemistry.

[35]  E. Nishida,et al.  Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.

[36]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[37]  S. Tashiro,et al.  ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.

[38]  R. Pestell,et al.  Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Mahlon D. Johnson,et al.  Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis , 1997, The Journal of cell biology.

[40]  K. Irie,et al.  A Novel Kinase Cascade Mediated by Mitogen-activated Protein Kinase Kinase 6 and MKK3* , 1996, The Journal of Biological Chemistry.

[41]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[42]  K. Geoghegan,et al.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.

[43]  R. Sidman,et al.  Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice , 1996, Nature.

[44]  K. Irie,et al.  Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.

[45]  R. O’Keefe,et al.  TGF-beta signaling in chondrocytes. , 2005, Frontiers in bioscience : a journal and virtual library.

[46]  A. Poole,et al.  Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.

[47]  W. B. van den Berg,et al.  Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. , 2000, Osteoarthritis and cartilage.

[48]  X. Tong,et al.  Transforming Growth Factor- (cid:1) 1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase , 2022 .